Spina Bifida Market 2018; Neurological Disorders | Projected to Boost the Market Growth | Healthy CAGR of ~ 8.0% - Forecast Period 2023

Spina Bifida Market Highlights:

Spina bifida is a neural tube defect in which a group of cells that develops into the spinal cord and brain, fails to close completely during embryonic development.A number of factors such as increasing technological advancements, rising awareness, increased incidence of spina bifida, related complications, unmet medical needs, improving regulatory framework, increasing government assistance, increasing adoption rate, and improvement in funding and reimbursement policies are few factors propelling the growth of the global spina bifida market.

Get Exclusive Sample Report @ https://www.marketresearchfuture.com/sample_request/5643

However, cost of treatment, side-effects of surgeries, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the review period.

It is estimated that the spina bifida market is expected to grow at a CAGR 8.0% during the forecast period of 2017-2023.

Spina Bifida Market Key Players:

Some of key the players in the global spina bifida market are B. Braun Melsungen AG, Boston Scientific, C.B. Fleet, C.R. Bard, Inc., Coloplast A/S, ConvaTec Group plc, Cook Medical, Covidien Private Ltd., Dynarex Corporation, Ethicon, Fujifilm, Hollister Incorporated, KARL STORZ, Medline Industries, Medtronic plc, Olympus, Pacific Hospital Supply Co., Ltd., Smith & Nephew, Stryker, Teleflex Incorporation, Wellspect Healthcare, and others.

Spina Bifida Market Scenario:     

Spina bifida is a congenital disorder that results in the malformation of the spinal cord. The condition is more common among Hispanics and whites, and the prevalence females are more likely to get affected than males.

On considering historical prevalence data of spina bifida in northeast China, during 2006-2015, it is found that a total of 2,029 cases of spina bifida were identified from 3,248,954 live births i.e. 6.25/10,000 live births. The disease is found to be highly prevalent in Chaoyang, Fuxin, and Huludao cities of China. According to the 2013 study conducted by Healthcare Cost and Utilization Project, hospitalization cost related to spina bifida was more than USD 600 million in 2013 for people of all ages.

Get Your Customized Report @ https://www.marketresearchfuture.com/reports/spina-bifida-market-5643

Spina Bifida Market Segmentation:

The global spina bifida market is segmented on the basis of type, diagnosis, treatment, and end user.

On the basis of the type, the market is classified as occulta, closed neural tube defects, meningocele, and myelomeningocele.

On the basis of the diagnosis, the market is classified as blood tests, ultrasound, amniocentesis, and others. The blood tests segment is further classified as maternal serum alpha-fetoprotein (MSAFP) test, test to confirm high AFP levels, and other blood tests.

Spina Bifida Market Intended Audience:

Pharmaceutical Companies
Medical Device Companies
Research and Development (R&D) Companies
Diagnostic Laboratories
Government Research Institute
Academic Institutes and Universities
Spina Bifida Market Regional Analysis:

The Americas dominate the spina bifida market owing to the rising occurrence of spina bifida in this region, and technological advancements. According to the statistics suggested by Centers for Disease Control and Prevention (CDC), around 1,500 babies are born with spina bifida every year in the United States. It is also reported that Hispanic women have the highest rate of having children affected with spina bifida as compared to non-Hispanic black or non-Hispanic white women.

Europe holds the second position in the spina bifida market. It is expected that the government support towards research & development expenditure, and amendments in reimbursement policies in the healthcare is likely to drive the European spina bifida market.

Asia Pacific is the fastest growing spina bifida market owing to a huge patient pool and continuous developments in healthcare technology. Healthcare expenditure is found to be improving in various Asia Pacific regions. According to the data suggested by the Australian Institute of Health and Welfare, during the year 2015-16, the total health expenditure was USD 170.4 billion i.e. 3.6% higher than the expenditure of 2014-2015.

The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.

Spina Bifida Market Table of Content:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition 

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

TOC Continued…!

Get Discount @ https://www.marketresearchfuture.com/check-discount/5643

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.